BUSINESS4 years ago
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Maintains A Cash Balance Of $127 Million: Reports Revenues Of $700,000 In Q4 2020
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) generated $700,000 from its licenses and awards in Q4 2020. Its operating expenses declined marginally to $21.5 million in Q4 2020....